Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction.
Corticobasal degeneration (CBD) typically manifests as progressive asymmetric rigidity and apraxia, although other non-motor presentations have been reported. We report two patients with pathologically diagnosed CBD who presented with prominent visuospatial dysfunction. The pathological changes were maximal in the visual association cortices, but absent in 31 cases of pathologically proven CBD with more typical antemortem features. Underlying CBD should be considered in the differential diagnosis of patients with findings reflecting posterior cerebral dysfunction.
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
D F
DF
Tang-Wai
K A
KA
Josephs
B F
BF
Boeve
D W
DW
Dickson
J E
JE
Parisi
R C
RC
Petersen
D000368:Aged; D000381:Agraphia / Q000209:etiology; D001072:Apraxias / Q000209:etiology; D001921:Brain / Q000473:pathology; D018450:Disease Progression; D004410:Dyslexia / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D005862:Gerstmann Syndrome / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019636:Neurodegenerative Diseases / Q000150:complications* / Q000175:diagnosis* / Q000503:physiopathology; D009460:Neurologic Examination; D009483:Neuropsychological Tests; D020734:Parkinsonian Disorders / Q000209:etiology; D014786:Vision Disorders / Q000209:etiology*